| dc.creator |
Siriopol, Dimitrie |
|
| dc.creator |
Dumea, Raluca |
|
| dc.creator |
Badarau, Silvia |
|
| dc.creator |
Kanbay, Mehmet |
|
| dc.creator |
GAVRİLOVİCİ, Cristina |
|
| dc.creator |
AFŞAR, Barış |
|
| dc.creator |
COVİC, Adrian |
|
| dc.creator |
Voroneanu, Luminita |
|
| dc.date |
2017-11-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T10:50:54Z |
|
| dc.date.available |
2020-10-06T10:50:54Z |
|
| dc.identifier |
a211204d-7552-4601-9ef5-2a6e994fe2bc |
|
| dc.identifier |
10.1007/s11255-017-1697-5 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/a211204d-7552-4601-9ef5-2a6e994fe2bc/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/68024 |
|
| dc.description |
Background In the last decade, despite constant investigation, no current single treatment has been able to decrease the incidence of diabetic nephropathy and to significantly reduce progression of diabetic CKD. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Addition of silymarin to renin-angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial |
|
| dc.type |
info:eu-repo/semantics/article |
|